⌘K

Home/Filings/5/0001104659-22-020827

5//SEC Filing

Griffiths Graham 5

Accession 0001104659-22-020827

CIK 0001828185other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 7:55 PM ET

Size

20.2 KB

Accession

0001104659-22-020827

Insider Transaction Report

Form 5

Period: 2021-12-31

Vaccitech plcVACC

Griffiths Graham

Chief Business Officer

Transactions

Exercise/Conversion
Ordinary Shares
2021-12-17$0.00/sh+102,279$41→ 102,379 total
Exercise/Conversion
Ordinary Shares
2021-12-17$0.00/sh+5,794$2→ 108,173 total
Exercise/Conversion
Ordinary Shares
2021-12-17$0.00/sh+4,636$2→ 112,809 total
Exercise/Conversion
Ordinary Shares
2021-12-17$0.00/sh+3,090$1→ 115,899 total
Exercise/Conversion
Share Option (Right to Buy)
2021-12-17−102,279→ 0 total
Exercise: $0.00Exp: 2028-02-16→ Ordinary Shares
Exercise/Conversion
Share Option (Right to Buy)
2021-12-17−5,794→ 1,931 total
Exercise: $0.00Exp: 2028-02-16→ Ordinary Shares
Exercise/Conversion
Share Option (Right to Buy)
2021-12-17−4,636→ 4,634 total
Exercise: $0.00Exp: 2029-08-14→ Ordinary Shares
Exercise/Conversion
Share Option (Right to Buy)
2021-12-17−3,090→ 9,270 total
Exercise: $0.00Exp: 2030-01-08→ Ordinary Shares

Footnotes (5)

[F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
[F2]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on October 16, 2018. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
[F3]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2019. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
[F4]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
[F5]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.

Documents

1 file

5
tm226469-7_5seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1

filerCIK 0001851630

Filing Metadata

Form type: 5
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 7:55 PM ET
Size: 20.2 KB

View on SEC.gov